<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The possible neuroprotective effect of <z:chebi fb="28" ids="17026">progesterone</z:chebi>, a steroid hormone, on <z:hpo ids='HP_0011009'>acute</z:hpo> phase changes in a mouse model of <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> induced by bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (BCAO) was studied </plain></SENT>
<SENT sid="1" pm="."><plain>A total of 72 male mice were included in the study </plain></SENT>
<SENT sid="2" pm="."><plain>The BCAO model was used to induce partial global <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Morphological assessment included measurement of <z:mpath ids='MPATH_124'>infarct</z:mpath> size and <z:hpo ids='HP_0002181'>brain oedema</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Post-ischaemic <z:hpo ids='HP_0001250'>seizure</z:hpo> susceptibility was assessed using a subconvulsive dose of pentylenetetrazole (30 mgkg(-1) i.p.) </plain></SENT>
<SENT sid="5" pm="."><plain>Biochemical estimations included <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha (TNF-alpha) levels and enzyme parameters such as <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation, <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase, catalase and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase, and protein estimation </plain></SENT>
<SENT sid="6" pm="."><plain>BCAO induced a significant <z:mpath ids='MPATH_124'>infarct</z:mpath> size and <z:hpo ids='HP_0000969'>oedema</z:hpo> in the saline-treated control group, along with an increase in <z:mp ids='MP_0003674'>oxidative stress</z:mp>, indicated by increased <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and decreased levels of <z:chebi fb="11" ids="22586">antioxidants</z:chebi> such as <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase, catalase and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="28" ids="17026">Progesterone</z:chebi> (15 mgkg(-1) i.p.) administration showed a neuro-protective effect by significantly reducing the cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> size as compared with the control group </plain></SENT>
<SENT sid="8" pm="."><plain>Post-ischaemic <z:hpo ids='HP_0001250'>seizure</z:hpo> susceptibility was also reduced as the number of positive responders decreased </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0002181'>Brain oedema</z:hpo> subsided, but not significantly </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="28" ids="17026">Progesterone</z:chebi> significantly reduced TNF-alpha levels compared with the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> group </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="28" ids="17026">Progesterone</z:chebi> improved levels of <z:hpo ids='HP_0000001'>all</z:hpo> the <z:chebi fb="11" ids="22586">antioxidants</z:chebi>, indicating activity against <z:mp ids='MP_0003674'>oxidative stress</z:mp> induced by BCAO </plain></SENT>
<SENT sid="12" pm="."><plain>The results demonstrate the neuroprotective effect of <z:chebi fb="28" ids="17026">progesterone</z:chebi> against ischaemic insult, suggesting a role for the steroid as a neuroprotective agent </plain></SENT>
</text></document>